In another study using humanized mice and KHOS heterotopic xenografts, researchers showed increased tumor infiltration of CD4+ and CD8+ T cells and reduced lung metastasis in mice treated with the immune checkpoint inhibitor nivolumab, although no effect on primary tumor growth was observed [76]. This evidence concerns the gene CD4 and neoplasm.